List of Tables
Table 1. Global Biopharma & Cosmetics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Ointments
Table 3. Key Players of Creams
Table 4. Key Players of Gel
Table 5. Key Players of Others
Table 6. Global Biopharma & Cosmetics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Biopharma & Cosmetics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Biopharma & Cosmetics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Biopharma & Cosmetics Market Share by Region (2020-2025)
Table 10. Global Biopharma & Cosmetics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Biopharma & Cosmetics Market Share by Region (2026-2031)
Table 12. Biopharma & Cosmetics Market Trends
Table 13. Biopharma & Cosmetics Market Drivers
Table 14. Biopharma & Cosmetics Market Challenges
Table 15. Biopharma & Cosmetics Market Restraints
Table 16. Global Biopharma & Cosmetics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Biopharma & Cosmetics Market Share by Players (2020-2025)
Table 18. Global Top Biopharma & Cosmetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma & Cosmetics as of 2024)
Table 19. Ranking of Global Top Biopharma & Cosmetics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Biopharma & Cosmetics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Biopharma & Cosmetics, Headquarters and Area Served
Table 22. Global Key Players of Biopharma & Cosmetics, Product and Application
Table 23. Global Key Players of Biopharma & Cosmetics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Biopharma & Cosmetics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Biopharma & Cosmetics Revenue Market Share by Type (2020-2025)
Table 27. Global Biopharma & Cosmetics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Biopharma & Cosmetics Revenue Market Share by Type (2026-2031)
Table 29. Global Biopharma & Cosmetics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Biopharma & Cosmetics Revenue Market Share by Application (2020-2025)
Table 31. Global Biopharma & Cosmetics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Biopharma & Cosmetics Revenue Market Share by Application (2026-2031)
Table 33. North America Biopharma & Cosmetics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Biopharma & Cosmetics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Biopharma & Cosmetics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Biopharma & Cosmetics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Biopharma & Cosmetics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Biopharma & Cosmetics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Biopharma & Cosmetics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Biopharma & Cosmetics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Biopharma & Cosmetics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Biopharma & Cosmetics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Biopharma & Cosmetics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biopharma & Cosmetics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Biopharma & Cosmetics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Biopharma & Cosmetics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Biopharma & Cosmetics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Johnson & Johnson Company Details
Table 49. Johnson & Johnson Business Overview
Table 50. Johnson & Johnson Biopharma & Cosmetics Product
Table 51. Johnson & Johnson Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 52. Johnson & Johnson Recent Development
Table 53. Roche Company Details
Table 54. Roche Business Overview
Table 55. Roche Biopharma & Cosmetics Product
Table 56. Roche Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 57. Roche Recent Development
Table 58. Novartis Company Details
Table 59. Novartis Business Overview
Table 60. Novartis Biopharma & Cosmetics Product
Table 61. Novartis Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 62. Novartis Recent Development
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Biopharma & Cosmetics Product
Table 66. Pfizer Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Sanofi Company Details
Table 69. Sanofi Business Overview
Table 70. Sanofi Biopharma & Cosmetics Product
Table 71. Sanofi Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 72. Sanofi Recent Development
Table 73. Eli Lilly Company Details
Table 74. Eli Lilly Business Overview
Table 75. Eli Lilly Biopharma & Cosmetics Product
Table 76. Eli Lilly Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 77. Eli Lilly Recent Development
Table 78. GSK Company Details
Table 79. GSK Business Overview
Table 80. GSK Biopharma & Cosmetics Product
Table 81. GSK Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 82. GSK Recent Development
Table 83. Bayer Company Details
Table 84. Bayer Business Overview
Table 85. Bayer Biopharma & Cosmetics Product
Table 86. Bayer Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 87. Bayer Recent Development
Table 88. Merck & Co Company Details
Table 89. Merck & Co Business Overview
Table 90. Merck & Co Biopharma & Cosmetics Product
Table 91. Merck & Co Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 92. Merck & Co Recent Development
Table 93. L' OREAL Company Details
Table 94. L' OREAL Business Overview
Table 95. L' OREAL Biopharma & Cosmetics Product
Table 96. L' OREAL Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 97. L' OREAL Recent Development
Table 98. Unilever Company Details
Table 99. Unilever Business Overview
Table 100. Unilever Biopharma & Cosmetics Product
Table 101. Unilever Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 102. Unilever Recent Development
Table 103. Procter & Gamble Company Details
Table 104. Procter & Gamble Business Overview
Table 105. Procter & Gamble Biopharma & Cosmetics Product
Table 106. Procter & Gamble Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 107. Procter & Gamble Recent Development
Table 108. Estee Lauder Company Details
Table 109. Estee Lauder Business Overview
Table 110. Estee Lauder Biopharma & Cosmetics Product
Table 111. Estee Lauder Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 112. Estee Lauder Recent Development
Table 113. Kao Company Details
Table 114. Kao Business Overview
Table 115. Kao Biopharma & Cosmetics Product
Table 116. Kao Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 117. Kao Recent Development
Table 118. Shiseido Company Details
Table 119. Shiseido Business Overview
Table 120. Shiseido Biopharma & Cosmetics Product
Table 121. Shiseido Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 122. Shiseido Recent Development
Table 123. Beiersdorf Company Details
Table 124. Beiersdorf Business Overview
Table 125. Beiersdorf Biopharma & Cosmetics Product
Table 126. Beiersdorf Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 127. Beiersdorf Recent Development
Table 128. Henkel Company Details
Table 129. Henkel Business Overview
Table 130. Henkel Biopharma & Cosmetics Product
Table 131. Henkel Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 132. Henkel Recent Development
Table 133. Shanghai Jahwa Company Details
Table 134. Shanghai Jahwa Business Overview
Table 135. Shanghai Jahwa Biopharma & Cosmetics Product
Table 136. Shanghai Jahwa Revenue in Biopharma & Cosmetics Business (2020-2025) & (US$ Million)
Table 137. Shanghai Jahwa Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Biopharma & Cosmetics Picture
Figure 2. Global Biopharma & Cosmetics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biopharma & Cosmetics Market Share by Type: 2024 VS 2031
Figure 4. Ointments Features
Figure 5. Creams Features
Figure 6. Gel Features
Figure 7. Others Features
Figure 8. Global Biopharma & Cosmetics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Biopharma & Cosmetics Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceuticals, OTC Case Studies
Figure 11. Cosmetics Case Studies
Figure 12. Biopharma & Cosmetics Report Years Considered
Figure 13. Global Biopharma & Cosmetics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Biopharma & Cosmetics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Biopharma & Cosmetics Market Share by Region: 2024 VS 2031
Figure 16. Global Biopharma & Cosmetics Market Share by Players in 2024
Figure 17. Global Top Biopharma & Cosmetics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharma & Cosmetics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Biopharma & Cosmetics Revenue in 2024
Figure 19. North America Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Biopharma & Cosmetics Market Share by Country (2020-2031)
Figure 21. United States Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Biopharma & Cosmetics Market Share by Country (2020-2031)
Figure 25. Germany Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Biopharma & Cosmetics Market Share by Region (2020-2031)
Figure 33. China Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Biopharma & Cosmetics Market Share by Country (2020-2031)
Figure 41. Mexico Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Biopharma & Cosmetics Market Share by Country (2020-2031)
Figure 45. Turkey Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Biopharma & Cosmetics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Johnson & Johnson Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 49. Roche Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 52. Sanofi Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 53. Eli Lilly Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 54. GSK Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 55. Bayer Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 56. Merck & Co Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 57. L' OREAL Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 58. Unilever Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 59. Procter & Gamble Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 60. Estee Lauder Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 61. Kao Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 62. Shiseido Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 63. Beiersdorf Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 64. Henkel Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 65. Shanghai Jahwa Revenue Growth Rate in Biopharma & Cosmetics Business (2020-2025)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed